HIGHLIGHTS
- who: Matteo Righini and collaborators from the Department of Experimental, Diagnostic and Specialty Medicine, University of, Italy have published the Article: Renal Toxicities in Cancer Patients Receiving Immune-Checkpoint Inhibitors: A Meta-Analysis, in the Journal: (JOURNAL)
- what: Ofauthors these, 5706 were primarily excluded at least one of the following reasons: on PubMed, EMBASE, Cochrane Library, focused on the efficacy and safety of ICIs in review articles, case reports, systematic review, meta-analysis, editorials, letters, or comcancer patients.
- how: The authors evaluated Relative Risk (RR) as the ratio betweenThe incidence toxicity in experimental . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.